EMAIL DETAILS

Agreed. We may want to share the entire article with the Board - provide a sense of what we face.

----- Original Message -----
From: Skip Lockwood <skip@zerocancer.org>
To: Mike Smith
Cc: <kevin@zerocancer.org> <kevin@zerocancer.org>; Hunter Biden (hbiden@obblaw.com) <hbiden@rosemontseneca.com>
Sent: Mon Mar 28 08:42:08 2011
Subject: Re: fyi

Well, this is not good news but at least it is not new news. I love how cavalier some people are with time. How much do you think you life is worth each month? It is so easy to make budget cuts and cost savings on other people's lives.

Stepping off the soap box now.

--Skip

Skip Lockwood
ZERO -- The Project to End Prostate Cancer
Building Generation ZERO, the first generation of men free from prostate cancer

Sent from my iPad

On Mar 28, 2011, at 6:16 AM, "Mike Smith" <msmith@cgagroup.com> wrote:


THE $93,000 QUESTION – If anything is too expensive for Medicare, it just might be a prostate cancer therapy that costs $93,000 and gives men, on average, an extra four months to live. The decision is due March 30, when CMS must decide whether Medicare will pay for Provenge, a cancer therapy. If CMS decides not to cover it, the agency could open itself up to the “government rationing” charges again (because Don Berwick was really missing those). And if the agency decides to cover it, the Obama administration will lose a lot of its talking points about controlling health care spending. The POLITICO Pro Story. http://politico.pro/euyY9f <Pulse:%20NAIC%20won%27t%20vote%20yet%20on%20broker%20bill%20-%201099%20repeal%20vote%20possible%20this%20week%20-%20Sebelius:%20I%27m%20staying%20-%20Hawaii%20says%20no%20to%20waiver.EML?Cmd=open#story2251>